
Policy & Acquisitions
Mergers & Acquisitions
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Mergers & Acquisitions
Mergers & AcquisitionsChiesi Seals a Strategic Win with $1.9B KalVista AcquisitionChiesi Group will acquire KalVista Pharmaceuticals in a $1.9 billion deal, adding the first oral on-demand treatment for Hereditary Angioedema and strengthening its rare disease portfolio.Fact-Checked
Mergers & AcquisitionsTeva to Acquire Emalex and Add Tourette Drug EcopipamTeva Pharmaceuticals will acquire Emalex Biosciences and its lead asset ecopipam, a late-stage therapy for pediatric Tourette syndrome that met its Phase 3 primary endpoint.Fact-Checked
Mergers & AcquisitionsProfluent and Eli Lilly Chase the ‘Holy Grail’ of DNA EditingProfluent has entered a multi-program collaboration with Eli Lilly to develop AI-designed recombinases for site-specific DNA editing.Fact-Checked
Mergers & AcquisitionsBioMarin Bolsters Its Rare Disease Portfolio Through Amicus AcquisitionBioMarin has finalized its $4.8 billion acquisition of Amicus Therapeutics, strengthening its rare disease portfolio with approved therapies for Fabry and Pompe diseases and a late-stage kidney disease…Fact-Checked
Mergers & AcquisitionsEli Lilly Bets Big on Next-Gen JAK2 Science with Ajax Therapeutics DealEli Lilly and Company will acquire Ajax Therapeutics in a deal worth up to $2.3 billion, centered on AJ1-11095, a novel Type II JAK2 inhibitor in early clinical…Fact-Checked
Mergers & AcquisitionsSun Pharma Acquires Organon in $11.75 Billion DealSun Pharma $11.75 billion acquisition of Organon strengthens its position in women’s health and biosimilars while expanding global scale and portfolio diversification.Fact-Checked
Mergers & AcquisitionsSerum Institute Joins VaxThera to Expand Vaccine Access in ColombiaVaxThera and Serum Institute of India form a strategic collaboration to expand vaccine production in Colombia, aiming to improve access, reduce import reliance, and enhance regional health resilience.Fact-Checked
Mergers & AcquisitionsSerum Institute of India Teams with Oxford to Reinforce the Fight Against Malaria with R78COxford and Serum Institute of India expand their partnership with a new licence for the R78C malaria vaccine candidate, aiming to improve efficacy through a multi-stage approach and…Fact-Checked
Mergers & AcquisitionsAbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinEAbbVie reported an FDA Complete Response Letter for trenibotulinumtoxinE, focused on manufacturing details, while clinical data supporting safety and efficacy remains intact.Fact-Checked
Mergers & AcquisitionsApotex to Acquire Cumberland’s Branded Drug Portfolio in $100M DealCumberland Pharmaceuticals has agreed to sell its branded commercial portfolio to Apotex for $100 million.Fact-Checked
Mergers & AcquisitionsAmneal Bets Big on Biosimilars with Kashiv AcquisitionAmneal Pharmaceuticals, Inc. has agreed to acquire Kashiv BioSciences, LLC in a transaction combining cash, equity, and milestone-based payments.Fact-Checked
Mergers & AcquisitionsMerck Builds AI-Enabled Enterprise with Support from Google CloudMerck has entered a multi-year collaboration with Google Cloud to integrate advanced AI technologies, including Gemini Enterprise, across its operations to improve efficiency, accelerate drug development, and enhance…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.